1. Penaloza, D. & Arias-Stella, J. The heart and pulmonary circulation at high
altitudes: healthy highlanders and chronic mountain sickness. Circulation. 115,
1132–1146 (2007).
2. West, J. B., Schoene, R. B. &Milledge, J. S. High Altitude Medicine and Physiology
(Hodder Arnold, London, 2007).
3. Calbet, J. A. et al. Why is VO2 max after altitude acclimatization still reduced
despite normalization of arterial O2 content? Am J Physiol Regul Integr Comp
Physiol. 284, R304–R316 (2003).
4. Grocott, M. P. et al. Arterial blood gases and oxygen content in climbers on Mount
Everest. N Engl J Med. 360, 140–149 (2009).
5. Beall, C. M. et al. Natural selection on EPAS1 (HIF2alpha) associated with low
hemoglobin concentration in Tibetan highlanders. Proc Natl Acad Sci USA. 107,
11459–11464 (2010).
6. Yi, X. et al. Sequencing of 50 human exomes reveals adaptation to high altitude.
Science. 329, 75–78 (2010).
7. Aragones, J. et al. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia
tolerance by reprogramming basal metabolism. Nat Genet. 40, 170–180 (2008).
8. Grocott, M., Montgomery, H. & Vercueil, A. High-altitude physiology and
pathophysiology: implications and relevance for intensive care medicine. Crit
Care. 11, 203 (2007).
9. Levett, D. Z. et al. Design and conduct of Caudwell Xtreme Everest: an
observational cohort study of variation in human adaptation to progressive
environmental hypoxia. BMC Med Res Methodol. 10, 98 (2010).
10. Moncada, S., Palmer, R. M. & Higgs, E. A. Nitric oxide: physiology,
pathophysiology, and pharmacology. Pharmacol Rev. 43, 109–142 (1991).
11. Wink, D. A. et al. Mechanisms of the antioxidant effects of nitric oxide. Antioxid
Redox Signal. 3, 203–213 (2001).
12. Jobgen,W. S., Fried, S. K., Fu, W. J., Meininger, C. J. &Wu, G. Regulatory role for
the arginine-nitric oxide pathway in metabolism of energy substrates. J Nutr
Biochem. 17, 571–588 (2006).
13. Taylor, C. T. & Moncada, S. Nitric oxide, cytochrome c oxidase, and the cellular
response to hypoxia. Arterioscler Thromb Vasc Biol. 30, 643–647 (2010).
14. Dosek, A., Ohno, H., Acs, Z., Taylor, A. W. & Radak, Z. High altitude and
oxidative stress. Respir Physiol Neurobiol. 158, 128–131 (2007).
15. Bru¨ne, B. & Zhou, J. Hypoxia-inducible factor-1alpha under the control of nitric
oxide. Methods Enzymol. 435, 463–478 (2007).
16. Lundberg, J. O., Weitzberg, E. & Gladwin, M. T. The nitrate-nitrite-nitric oxide
pathway in physiology and therapeutics. Nat Rev Drug Discov. 7, 156–167 (2008).
17. Feelisch, M. et al. Tissue processing of nitrite in hypoxia: an intricate interplay of
nitric oxide-generating and -scavenging systems. J Biol Chem. 283, 33927–33934
(2008).
18. Erzurum, S. C. et al. Higher blood flow and circulating NO products offset highaltitude
hypoxia among Tibetans. Proc Natl Acad Sci USA. 104, 17593–17598
(2007).
19. Martin, D. S. et al. Changes in sublingual microcirculatory flow index and vessel
density on ascent to altitude. Exp Physiol. 95, 880–891 (2010).
20. Bailey, S. J. et al. Dietary nitrate supplementation reduces the O2 cost of lowintensity
exercise and enhances tolerance to high-intensity exercise in humans.
J Appl Physiol. 107, 1144–1155 (2009).
21. Larsen, F. J. et al. Dietary inorganic nitrate improves mitochondrial efficiency in
humans. Cell Metab. 13, 149–159 (2011).
22. Moncada, S., Palmer, R. M. & Gryglewski, R. J. Mechanism of action of some
inhibitors of endothelium-derived relaxing factor. Proc Natl Acad Sci USA. 83,
9164–9168 (1986).
23. Marconi, C. Economy of locomotion in high-altitude Tibetan migrants exposed to
normoxia. J Physiol. 569, 667–675 (2005).
24. Spoto, G., Di Giulio, C., Contento, A. &Di Stilio, M. Hypoxic and hyperoxic effect
on blood phosphodiesterase activity in young and old rats. Life Sci. 63, PL349–
PL353 (1998).
25. Butler, A. R. & Feelisch, M. Therapeutic uses of inorganic nitrite and nitrate: From
the past to the future. Circulation. 117, 2151–2159 (2008).
26. Cosby, K. et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates
the human circulation. Nat Med. 9, 1498–1505 (2003).
27. Lauer, T. et al. Plasma nitrite rather than nitrate reflects regional endothelial nitric
oxide synthase activity but lacks intrinsic vasodilator action. Proc Natl Acad Sci
USA. 98, 12814–12819 (2001).
28. Bryan,N. S. et al.Nitrite is a signaling molecule and regulator of gene expression in
mammalian tissues. Nat Chem Biol. 1, 290–297 (2005).
29. Reichert, E. T. & Mitchell, S. W. On the physiological action of potassium nitrite.
Am J Med Sci. 156, 158–180 (1880).
30. Trzeciak, S. et al. Microcirculatory Alterations in Resuscitation and Shock
Investigators. Early microcirculatory perfusion derangements in patients with
severe sepsis and septic shock: relationship to hemodynamics, oxygen transport,
and survival. Ann Emerg Med. 49, 88–98 (2007).
31. Lipton, A. J. et al. S-nitrosothiols signal the ventilatory response to hypoxia.
Nature. 413, 171–174 (2001).
32. Sumbayev, V. V., Budde, A., Sumbayev, V. V., Budde, A., Zhou, J. & Bru¨ne,
B. HIF-1 alpha protein as a target for S-nitrosation. FEBS Lett. 535, 106–112
(2003).
33. Lima, B., Forrester, M. T., Hess, D. T. & Stamler, J. S. S-nitrosylation in
cardiovascular signaling. Circ Res. 106, 633–646 (2010).
34. Thomas, D. D. et al. The chemical biology of nitric oxide: implications in cellular
signaling. Free Radic Biol Med. 45, 18–31 (2008).
35. Martin, D. S., Khosravi, M., Grocott, M. P. &Mythen, M. G. Concepts in hypoxia
reborn. Crit Care. 14, 315 (2010).
36. Hayes, M. A. et al. Elevation of systemic oxygen delivery in the treatment of
critically ill patients. N Engl J Med. 330, 1717–1722 (1994).
37. Gattinoni, L. et al. A trial of goal-oriented hemodynamic therapy in critically ill
patients. SvO2 Collaborative Group. N Engl J Med. 333, 1025–1032 (1995).
38. Lopez, A. et al. Multiple-center, randomized, placebo-controlled, double-blind
study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients
with septic shock. Crit Care Med. 32, 21–30 (2004).
39. Whipp, B. J., Ward, S. A. &Wasserman, K. Respiratory markers of the anaerobic
threshold. Adv Cardiol. 35, 47–64 (1986).
40. Beaver, W. L., Wasserman, K. & Whipp, B. J. A new method for detecting
anaerobic threshold by gas exchange. J Appl Physiol. 60, 2020–2027 (1986).
41. Hansen, J. E., Sue, D. Y. & Wasserman, K. Predicted values for clinical exercise
testing. Am Rev Respir Dis. 129, S49–S55 (1984).
42. Whipp, B. J., Davis, J. A., Torres, F. & Wasserman, K. A test to determine
parameters of aerobic function during exercise. J Appl Physiol. 50, 217–221
(1981).
43. Huszczuk,A., Whipp, B. J.&Wasserman, K.Arespiratory gas exchange simulator
for routine calibration in metabolic studies. Eur Respir J. 3, 465–468 (1990).
44. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Resp Crit Care
Med. 167, 211–277 (2003).
45. De Backer, D. et al. How to evaluate the microcirculation: report of a round table
conference. Crit Care. 11, R101 (2007).
46. Rassaf, T., Bryan, N. S., Kelm, M. & Feelisch, M. Concomitant presence of
N-nitroso and S-nitroso proteins in human plasma. Free Radic Biol Med. 33,
1590–1596 (2002).